96 related articles for article (PubMed ID: 9767392)
1. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
2. Botulinum Toxins A and E Inflict Dynamic Destabilization on t-SNARE to Impair SNARE Assembly and Membrane Fusion.
Khounlo R; Kim J; Yin L; Shin YK
Structure; 2017 Nov; 25(11):1679-1686.e5. PubMed ID: 29033286
[TBL] [Abstract][Full Text] [Related]
3. Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.
Hackett G; Moore K; Burgin D; Hornby F; Gray B; Elliott M; Mir I; Beard M
Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29751611
[TBL] [Abstract][Full Text] [Related]
4. Use of a recombinant fluorescent substrate with cleavage sites for all botulinum neurotoxins in high-throughput screening of natural product extracts for inhibitors of serotypes A, B, and E.
Hines HB; Kim AD; Stafford RG; Badie SS; Brueggeman EE; Newman DJ; Schmidt JJ
Appl Environ Microbiol; 2008 Feb; 74(3):653-9. PubMed ID: 18083881
[TBL] [Abstract][Full Text] [Related]
5. Members of the synaptobrevin/vesicle-associated membrane protein (VAMP) family in Drosophila are functionally interchangeable in vivo for neurotransmitter release and cell viability.
Bhattacharya S; Stewart BA; Niemeyer BA; Burgess RW; McCabe BD; Lin P; Boulianne G; O'Kane CJ; Schwarz TL
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13867-72. PubMed ID: 12364587
[TBL] [Abstract][Full Text] [Related]
6. Block of transmitter release by botulinum C1 action on syntaxin at the squid giant synapse.
Marsal J; Ruiz-Montasell B; Blasi J; Moreira JE; Contreras D; Sugimori M; Llinás R
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14871-6. PubMed ID: 9405706
[TBL] [Abstract][Full Text] [Related]
7. A second SNARE role for exocytic SNAP25 in endosome fusion.
Aikawa Y; Lynch KL; Boswell KL; Martin TF
Mol Biol Cell; 2006 May; 17(5):2113-24. PubMed ID: 16481393
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia.
Barakauskas VE; Beasley CL; Barr AM; Ypsilanti AR; Li HY; Thornton AE; Wong H; Rosokilja G; Mann JJ; Mancevski B; Jakovski Z; Davceva N; Ilievski B; Dwork AJ; Falkai P; Honer WG
Neuropsychopharmacology; 2010 Apr; 35(5):1226-38. PubMed ID: 20072114
[TBL] [Abstract][Full Text] [Related]
9. Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.
Bröer S; Zolkowska D; Gernert M; Rogawski MA
Neuroscience; 2013 Nov; 252():253-61. PubMed ID: 23906638
[TBL] [Abstract][Full Text] [Related]
10. Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants.
Nonet ML; Saifee O; Zhao H; Rand JB; Wei L
J Neurosci; 1998 Jan; 18(1):70-80. PubMed ID: 9412487
[TBL] [Abstract][Full Text] [Related]
11. A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity.
Adler M; Shafer HF; Manley HA; Hackley BE; Nicholson JD; Keller JE; Goodnough MC
J Protein Chem; 2003 Jul; 22(5):441-8. PubMed ID: 14690246
[TBL] [Abstract][Full Text] [Related]
12. Botulinum neurotoxin serotypes detected by electrochemical impedance spectroscopy.
Savage AC; Buckley N; Halliwell J; Gwenin C
Toxins (Basel); 2015 May; 7(5):1544-55. PubMed ID: 25954998
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification of a SNAP-25-like SNARE protein in Paramecium.
Schilde C; Lutter K; Kissmehl R; Plattner H
Eukaryot Cell; 2008 Aug; 7(8):1387-402. PubMed ID: 18552286
[TBL] [Abstract][Full Text] [Related]
14. A Cell Line for Detection of Botulinum Neurotoxin Type B.
Rust A; Doran C; Hart R; Binz T; Stickings P; Sesardic D; Peden AA; Davletov B
Front Pharmacol; 2017; 8():796. PubMed ID: 29170639
[TBL] [Abstract][Full Text] [Related]
15. A novel role of C-terminus in introducing a functionally flexible structure critical for the biological activity of botulinum neurotoxin.
Feltrup TM; Patel K; Kumar R; Cai S; Singh BR
Sci Rep; 2018 Jun; 8(1):8884. PubMed ID: 29891845
[TBL] [Abstract][Full Text] [Related]
16. Effects of hyperkinetic, a beta subunit of Shaker voltage-dependent K+ channels, on the oxidation state of presynaptic nerve terminals.
Ueda A; Wu CF
J Neurogenet; 2008; 22(2):1-13. PubMed ID: 18428031
[TBL] [Abstract][Full Text] [Related]
17. SNARE Proteins in Synaptic Vesicle Fusion.
Palfreyman MT; West SE; Jorgensen EM
Adv Neurobiol; 2023; 33():63-118. PubMed ID: 37615864
[TBL] [Abstract][Full Text] [Related]
18. Recombinant botulinum neurotoxin serotype A1 in vivo characterization.
Périer C; Martin V; Cornet S; Favre-Guilmard C; Rocher MN; Bindler J; Wagner S; Andriambeloson E; Rudkin B; Marty R; Vignaud A; Beard M; Lezmi S; Kalinichev M
Pharmacol Res Perspect; 2021 Oct; 9(5):e00857. PubMed ID: 34632725
[TBL] [Abstract][Full Text] [Related]
19. Active Zone Material-Directed Orientation, Docking, and Fusion of Dense Core Vesicles Alongside Synaptic Vesicles at Neuromuscular Junctions.
Jung JH; Szule JA; Stouder K; Marshall RM; McMahan UJ
Front Neuroanat; 2018; 12():72. PubMed ID: 30271328
[TBL] [Abstract][Full Text] [Related]
20. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.
Pirazzini M; Rossetto O; Eleopra R; Montecucco C
Pharmacol Rev; 2017 Apr; 69(2):200-235. PubMed ID: 28356439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
